Compound ingredient supplier Medisca Inc. pays $21.75 Million to settle False Claims Act case on inflated average wholesale prices

Medisca Inc. (Medisca), has agreed to pay $21.75 million to settle allegations that it inflated its true Average Wholesale Prices (AWPs) for two ingredients used in compound prescriptions. Mediscaā€™s pricing scheme allegedly caused pharmacies that purchased those ingredients to submit false prescription claims to the Defense Health Agency, which administers the...
Continue reading…